Home/Filings/4/0000899243-20-014715
4//SEC Filing

Farrell Edward 4

Accession 0000899243-20-014715

CIK 0001596946other

Filed

May 31, 8:00 PM ET

Accepted

Jun 1, 4:05 PM ET

Size

17.8 KB

Accession

0000899243-20-014715

Insider Transaction Report

Form 4
Period: 2020-05-28
Transactions
  • Sale

    Ordinary Shares

    2020-05-28$7.40/sh12,811$94,80129,013 total
Holdings
  • Employee Stock Option (right to buy)

    Exercise: $8.00Exp: 2024-04-29Ordinary Shares (79,000 underlying)
    79,000
  • Employee Stock Option (right to buy)

    Exercise: $7.58Exp: 2027-05-23Ordinary Shares (40,000 underlying)
    40,000
  • Restricted Stock Units

    Ordinary Shares (30,000 underlying)
    30,000
  • Restricted Stock Units

    Ordinary Shares (55,000 underlying)
    55,000
  • Employee Stock Option (right to buy)

    Exercise: $15.17Exp: 2025-05-19Ordinary Shares (30,000 underlying)
    30,000
  • Restricted Stock Units

    Ordinary Shares (12,257 underlying)
    12,257
  • Employee Stock Option (right to buy)

    Exercise: $11.92Exp: 2026-05-31Ordinary Shares (30,000 underlying)
    30,000
  • Restricted Stock Units

    Ordinary Shares (2,232 underlying)
    2,232
  • Options to acquire ordinary shares

    Exp: 2023-04-10Ordinary Shares (96,000 underlying)
    96,000
Footnotes (13)
  • [F1]Restricted Stock Units convert into ordinary shares on a one-for-one basis.
  • [F10]On January 7, 2020, the Reporting Person was granted 2,232 Restricted Stock Units, vesting in three equal annual installments beginning January 7, 2021.
  • [F11]On May 24, 2020, the Reporting Person was granted 55,000 Restricted Stock Units, vesting in three equal annual installments beginning May 24, 2021.
  • [F12]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 25, 2020.
  • [F13]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.32 to $7.53, inclusive. The Reporting Person undertakes to provide to Quotient Limited and any security holder of Quotient Limited, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (13) to this Form 4.
  • [F2]All 30,000 options have vested and remain exercisable.
  • [F3]All 30,000 options have vested and remain exercisable.
  • [F4]The exercise price will be paid in pounds sterling, at GBP0.003 per share.
  • [F5]All 96,000 options have vested and remain exercisable.
  • [F6]All 79,000 options have vested and remain exercisable.
  • [F7]All 40,000 options have vested and remain exercisable.
  • [F8]On May 24, 2018, the Reporting Person was granted 36,773 Restricted Stock Units, of which 24,516 have vested and have been exercised. The remaining 12,257 Restricted Stock Units will vest on May 24, 2021.
  • [F9]On May 24, 2019, the Reporting Person was granted 45,000 Restricted Stock Units, of which 15,000 have vested and have been exercised. The remaining 30,000 Restricted Stock Units will vest in two equal installments on May 24, 2021 and May 24, 2022.

Issuer

Quotient Ltd

CIK 0001596946

Entity typeother

Related Parties

1
  • filerCIK 0001604629

Filing Metadata

Form type
4
Filed
May 31, 8:00 PM ET
Accepted
Jun 1, 4:05 PM ET
Size
17.8 KB